Trepatchayakorn Sirawut, Chaijitraruch Nataruks, Chongsrisawat Voranush, Chanakul Ankanee, Kongkiattikul Lalida, Samransamruajkit Rujipat
Department of Pediatrics, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Indian J Crit Care Med. 2021 Jul;25(7):812-816. doi: 10.5005/jp-journals-10071-23896.
Pediatric acute liver failure (PALF) is a life-threatening condition. Extracorporeal support has been applied for toxic metabolite clearance and serves as a bridging therapy to liver transplantation (LT) or to the regeneration of the liver, but evidence for treatment approaches is still lacking in the pediatric population. We aim to report our experience on therapeutic plasma exchange with high-volume continuous renal replacement therapy (TPE + HV-CRRT) as a promising supportive treatment for PALF.
A total of eight PALF cases aged 9 months to 14 years, weighing 10-50 kg., who were admitted to PICU King Chulalongkorn Memorial Hospital, Thailand and treated with TPE + HV-CRRT from January 2016 to September 2019 were reviewed. Patient demographic data, indications, technical aspects, and clinical outcomes were recorded.
All patients who underwent TPE + HV-CRRT showed clinical improvement regarding serum bilirubin levels and coagulation studies after the therapy. Complications from the therapy were hemodynamic instability, symptomatic fluid overload, and bleeding from catheter sites. Among these, 6 (75%) patients survived with 4 (50%) successful LTs and 2 (25%) spontaneous recovery. Two children (25%) died while on the transplantation list.
TPE + HV-CRRT can be used safely as a bridging therapy in children with PALF. As opposed to the adult population, higher volume of TPE or higher blood flow rate in pediatric patients might associate with hemodynamic instability during the procedure.
Trepatchayakorn S, Chaijitraruch N, Chongsrisawat V, Chanakul A, Kongkiattikul L, Samransamruajkit R. Therapeutic Plasma Exchange with Continuous Renal Replacement Therapy for Pediatric Acute Liver Failure: A Case Series from Thailand. Indian J Crit Care Med 2021;25(7):812-816.
小儿急性肝衰竭(PALF)是一种危及生命的疾病。体外支持已被用于清除有毒代谢产物,并作为肝移植(LT)或肝脏再生的过渡治疗,但小儿群体中治疗方法的证据仍然不足。我们旨在报告我们使用治疗性血浆置换联合高容量连续性肾脏替代疗法(TPE + HV-CRRT)作为PALF的一种有前景的支持性治疗的经验。
回顾了2016年1月至2019年9月期间入住泰国朱拉隆功国王纪念医院重症监护病房(PICU)、年龄9个月至14岁、体重10 - 50千克、接受TPE + HV-CRRT治疗的8例PALF病例。记录患者的人口统计学数据、适应症、技术方面和临床结果。
所有接受TPE + HV-CRRT治疗的患者在治疗后血清胆红素水平和凝血研究方面均有临床改善。治疗的并发症包括血流动力学不稳定、有症状的液体超负荷和导管部位出血。其中,6例(75%)患者存活,4例(50%)成功进行了肝移植,2例(25%)自发恢复。2名儿童(25%)在等待移植名单上死亡。
TPE + HV-CRRT可安全地用作PALF患儿的过渡治疗。与成人不同,小儿患者更高的TPE量或更高的血流速度可能与治疗过程中的血流动力学不稳定有关。
Trepatchayakorn S, Chaijitraruch N, Chongsrisawat V, Chanakul A, Kongkiattikul L, Samransamruajkit R. 小儿急性肝衰竭的治疗性血浆置换联合连续性肾脏替代疗法:来自泰国的病例系列。《印度危重症医学杂志》2021;25(7):812 - 816。